Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC
(1)
,
(1)
,
(1)
,
(1)
,
(1)
,
(1)
,
(1)
,
(1)
,
(1)
,
(1)
,
(1)
,
(2)
,
(1)
,
(3, 4, 1)
,
(1)
,
(1)
,
(1)
1
2
3
4
2
3
4
Philippe Rochigneux
- Function : Author
- PersonId : 754863
- IdHAL : philippe-rochigneux
- ORCID : 0000-0001-7932-0530
- IdRef : 159209404